Inside Precision Medicine
Verified
Magazine
Clinical OMICs is now Inside Precision Medicine
Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field.
Through its flagship Magazine, up-to-the-minute Website, suite of eNewsletters, and dynamic portfolio of broadcast events and multimedia, Inside Precision Medicine is the definitive voice for vigorous discussions and perspectives that span technological innovation and complex socio-economic and public policy issues, while offering pragmatic solutions to some of the misalignments that exist between a diverse group of stakeholders. Inside Precision Medicine embraces the challenge to think differently and to play its part in effecting real progress and change, focusing on scaling and streamlining the precision medicine continuum for the benefit of patients in need.
From our core areas of Translational Research, Molecular Diagnostics, Informatics, and Patient Care to our expanded coverage of Disease Indications and Payer/Regulatory issues, our best-in-class content informs, educates, and enlightens our diverse audience of researchers, pathologists, clinicians, executives, and other professionals. Source
Actions
Media Outlet details
| Scope | International, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesGuardant360 CDx Test Approved for Early, 'Serial' Use in Breast Cancer
Scientific illustration of a migrating breast cancer cell - 3d illustration In a first for breast cancer, the Guardant360 CDx test has been FDA approved as a companion diagnostic for “serial” use with AstraZeneca’s ETCAMAH (camizestrant) in certain patients, Guardant Health has announced. The test is for patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.
Targetable KRAS G12C Mutation Uncommon in Genitourinary Cancers
Credit: magicmine / Getty Images A comprehensive genomic profiling study involving more than 13,000 patients has shown that targetable G12C mutations in the KRAS oncogene are rare in genitourinary cancers, potentially limiting the role of routine testing and targeted treatment in these malignancies.
Palani Kumaresan: Roche Diagnostics Is Ramping Up—Should Illumina Be Worried?
Credit: Anand Purohit / Getty Images / Moment For the past year and a half, Roche Diagnostics has been drumming up interest around AXELIOS, its return to next-generation sequencing. The platform officially launched in late June and came out of the gate with an attention-grabbing result: a new world record for clinical sequencing of an entire human genome. But in NGS, better technology—at least on paper—does not always win.
Forcing Acute Myeloid Leukemia Cells to Run on Empty Shows Promise in Mice
Credit: Salah Uddin/ iStock / Getty Images Plus Scientists have developed a new strategy against acute myeloid leukemia (AML) that pushes cancer cells to keep working even after their energy supply has been disrupted, causing them to die from metabolic stress. The study, published in the journal Molecular Cancer, reports promising results from laboratory and animal experiments. The approach combines a newly designed molecule, called AcTor, with the existing anti-cancer drug ixazomib.
Researchers Call for Biologically-Tailored Treatment for Mantle Cell Lymphoma
Credit: xfzsy/Getty Images European researchers have proposed a biomarker-based treatment algorithm for patients with mantle cell lymphoma that could move treatment decisions beyond age and transplant eligibility toward individualized strategies based on disease biology and treatment response.
HLA Gene Variant Linked to Severe Reaction from Anti-Seizure Medication
U.S. researchers have identified a strong association between a variant of the human leukocyte antigen gene (HLA-A*32:01) and a severe adverse reaction that is induced by the antiseizure drug lamotrigine but note that this variant is not included in current commercial pharmacogenomic tests that screen new users for such events.
Inhibitory Neurons May Help Keep Adult Gliomas in Check
Credit: wildpixel / iStock / Getty Images Plus The electrical environment surrounding a brain tumor may influence its growth in opposing ways. While previous research has shown that neuronal activity can stimulate gliomas, a new study finds that signals from inhibitory neurons can suppress adult glioma growth by reducing calcium activity inside tumor cells.
Common European Genetic Variants Linked with Parkinson’s Progression
Credit: MarianVejcik/Getty Images Genetic variants commonly found in people of European descent are associated with accelerated progression of Parkinson’s disease (PD), research indicates. The findings, in JAMA Neurology, suggest common loss-of-function variants in the melanocortin 1 receptor (MC1R) gene, carried by more than 60% of individuals of European descent, are linked with faster motor decline.
Genetic Propensity to COPD, Air Pollution Impacts Lung Growth
Credit: artacet/Getty Images Research from Switzerland suggests that having a genetic propensity to developing the lung condition chronic obstructive pulmonary disease (COPD) can negatively impact lung development in children if they are also exposed to air pollution. COPD is a progressive condition, causing chronic bronchitis and emphysema, that can lead to persistent airflow limitation, breathlessness, and coughing.
Dried-Blood Method Enables Faster Diagnosis of Zika and Hepatitis C
Credit: Kateryna Kon/Science Photo Library/Getty Images A new diagnostic method enables the detection of hepatitis C and Zika virus directly from dried whole blood, potentially bringing faster testing to locations where conventional laboratory diagnostics are difficult to access. In a study published today in Science Advances, the new approach could overcome a major barrier to accessibility by eliminating the need for complex sample preparation steps.